Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion

Contraception

Volumn 73, Issue 5, 2006, Pages 525-527

  Kapp, Nathalie ^a   Borgatta, Lynn ^a   Ellis, Sacheen Carr ^a   Stubblefield, Phillip ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Medical abortion; Mifepristone; Misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MUSCLE CRAMP; NAUSEA; PAIN; PHYSICAL EXAMINATION; TELECONSULTATION; UTERUS; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PILOT PROJECTS; PREGNANCY;

EID: 33646071802     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.12.011     Document Type: Article

References (15)

1. Honkanen H., and von Hertzen H. Users' perspectives on medical abortion in Finland. Contraception 65 (2002) 419-423
2. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect 27 (1995) 142-148
3. Silvestre L., Dubois C., Renault M., Rezrani Y., Baulieu E.E., and Ulmann A. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue: a large-scale French experience. N Engl J Med 322 (1990) 645-648
4. Kelly R.W., and Bukman A. Antiprogestagenic inhibition of uterine prostaglandin inactivation: a permissive mechanism for uterine stimulation. J Steroid Biochem Mol Biol 37 (1990) 97-101
5. Schaff E.A., Fielding L.S., Westhoff C., et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 284 (2000) 1948-1953
6. Creinin M.D., Fox M.C., Teal S., Chen A., Schaff E.A., and Meyn L.A. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 103 (2004) 852-859
7. Schreiber C.A., Creinin M.D., Harwood B., and Murthy A.S. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days. Contraception 71 (2005) 447-450
8. Murthy A.S., Creinin M.D., Harwood A.S., and Schreiber C.A. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. Contraception 71 (2005) 333-336
9. Creinin M.D., Pymar H.C., and Schwartz J.L. Mifepristone 100 mg in abortion regimens. Obstet Gynecol 98 (2001) 434-439
10. Heikinheimo O. Pharmacokinetics of the antiprogesterone RU 486 in women during multiple dose administration. J Steroid Biochem 32 (1989) 21-25
11. Peyron R., Aubeny E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 328 (1993) 1509-1513
12. Schaff E.A., Eisinger S.H., Stadalius L.S., Franks P., Gore B.Z., and Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 59 (1999) 1-6
13. Goldberg A.B., Fielding S.L., Eisinger S.H., Stadalius L.S., and Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 61 (2000) 41-46
14. Borgatta L., Mullally B., Vargovic O., Gittinger E., and Chen A. Misoprostol as the primary agent for medical abortion in a low-income urban setting. Contraception 70 (2004) 121-126
15. Stubblefield P.G., Carr-Ellis S., and Borgatta L. Methods for induced abortion. Obstet Gynecol 104 (2004) 174-185